|
Reference #: JON-1017-311518
Submit Date: 03/28/2002 03:54:42-0500
Presentation Type: platform
CONTACT: Alexandra Jones
Department of Medicine (Dermatology), University of Sydney Sydney, NSW 2006
Telomerase reactivation and p53 mutation
in solar keratosis
AUTHOR GROUP:
Alexandra Jones 1, 2 Department of Medicine (Dermatology) University of Sydney, Sydney, NSW 2006 1 Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, Sydney, NSW 2050 2 Nita Agar 1, 2 Department of Medicine (Dermatology) University of Sydney, Sydney, NSW 2006 1 Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, Sydney, NSW 2050 2 Angela Nikolic 1, 2 Department of Medicine (Dermatology) University of Sydney, Sydney, NSW 2006 1 Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, Sydney, NSW 2050 2 Ross Barnetson 1, 2 Department of Medicine (Dermatology) University of Sydney, Sydney, NSW 2006 1 Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, Sydney, NSW 2050 2 Gary Halliday 1, 2 Department of Medicine (Dermatology) University of Sydney, Sydney, NSW 2006 1 Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, Sydney, NSW 2050 2
ABSTRACT: In Australia solar keratosis (SK) occur in nearly 100% of Caucasoid Australians over the age of 50. SK vary tremendously in their degree of dysplasia, less than 1% progress to squamous cell carcinoma (SCC) per year and they have a high rate of regression. Previous studies by our group showed that 50% of inflamed SK (ISK) were histologically SCC. Previous phenotypic analysis of this ISK group including p53 immunohistochemistry, suggested that ISKs (histologically still SK) might represent a recently transformed group of SKs. Telomerase reactivation, is thought to be a useful marker of malignant transformation and may be an early event in skin carcinogenesis. We analysed telomerase reactivation using the TRAP assay in 3mm punch biopsy specimens of normal skin, SK, ISK and SCC to determine if the ISKs might represent a distinct group of recently transformed SKs. 30% of normal skin, 40% of SKs, 100% of ISKs and 100% of SCCs were positive for telomerase. In contrast to other reports telomerase activity in normal skin did not correlate with sun exposure. As yet no histological parameters correlate with telomerase activity in the SKs but the ISKs showed increased dysplasia compared to the SK group. In order to determine whether ISKs represented a group of transformed SKs, exons 5 to 9 of the p53 gene were sequenced in a separate group of specimens. On average there were 0.66 and 0 mutations in sunexposed and non-sunexposed skin respectively and 8, 11.33 and 11.25 mutations in each SK, ISK and SCC respectively. Thus ISK showed a similar p53 mutational profile to SCC, whilst clinically and histologically resembling a SK. These results suggest that ISKs in particular, are proliferations of transformed neoplastic keratinocytes and may represent evolving SCC.
Keywords: Solar Keratosis, Telomerase, p53
|